Severe adverse cutaneous reactions induced by gefitinib combined with antihypertensive and antihyperlipidemic drugs in lung cancer: a case report

The incidence of lung cancer is increasing yearly worldwide, and targeted medicines are the main choice for lung cancer patients. However, there has been no relevant research about the analysis and adjustment of drug combinations for cancer patients with hypertension and hyperlipidemia until now. He...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Xiao, Fan, Guorong, Liu, Gaolin, Wang, Fan, Li, Qi, Liu, Xinyan, Zhu, Hong, Zhu, Ying, Lu, Jiguang, Wang, Shuowen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670352/
https://www.ncbi.nlm.nih.gov/pubmed/34459464
http://dx.doi.org/10.1097/CAD.0000000000001226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670352/
https://www.ncbi.nlm.nih.gov/pubmed/34459464
http://dx.doi.org/10.1097/CAD.0000000000001226

Ejemplares similares